|
| |
| | 66585 | | 29.06.2018 | | GlaxoSmithKline AG | | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Benlysta | Lösung zur subkutanen Injektion (Autoinjektor) | Lösung zur subkutanen Injektion (Autoinjektor) (Belimumabum 200 mg/ml) | L04AG04 | CI |
|
|
|